BusinessAXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS PatientsBy Nasdaq OMXJan 23, 2018, 2:02 PM UTC
BusinessTESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian CancerBy Nasdaq OMXNov 20, 2017, 12:01 PM UTC
BusinessNew Survey Finds Cloud Analytics Now Mainstream and Riding a Wave of Governed Self-ServiceBy Nasdaq OMXMar 6, 2017, 3:00 PM UTC
BusinessSummit Outlines Phase 3 Programme for Novel CDI Antibiotic Ridinilazole Following FDA and EMA Regulatory MeetingsBy Nasdaq OMXFeb 1, 2017, 12:01 PM UTC
BusinessSummit Outlines Phase 3 Programme for Novel CDI Antibiotic Ridinilazole Following FDA and EMA Regulatory MeetingsBy Nasdaq OMXFeb 1, 2017, 12:01 PM UTC
